JENNIFER CALNEN: Open Payments
NPI 1790956647 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,825 in 195 payments from 16 companies in 2025. Trend: 2023 $2,078 · 2024 $2,658 · 2025 $3,825
Food & beverage: $3,825
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 54 | $1,101 |
| Alkermes, Inc. | 37 | $550 |
| ABBVIE INC. | 27 | $474 |
| Neurocrine BioSciences, Inc. | 21 | $404 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $287 |
| Teva Pharmaceuticals USA, Inc. | 10 | $286 |
| Indivior Inc. | 7 | $220 |
| Janssen Pharmaceuticals, Inc | 10 | $181 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
Products named: REXULTI, VRAYLAR, INGREZZA, ARISTADA, CAPLYTA, SUBLOCADE, VIVITROL, ABILIFY MAINTENA.
Industry payments across MA — which companies pay providers there.
